Satsuma Pharmaceuticals Inc (STSA) is lower by Friday morning, with the stock falling -1.87% in pre-market trading to 1.05. STSA's short-term technical score of 17 indicates that the stock has traded less bullishly over the last month than 83% of stocks on the market. In the Biotechnology industry, which ranks 106 out of 146 industries, the stock ranks higher than 23% of stocks. Satsuma Pharmaceuticals Inc has risen 27.38% over the past month, closing at $0.70 on March 31. During this period of time, the stock fell as low as $0.66 and as high as $1.47. STSA has an average analyst recommendation of Buy. The company has an average price target of $2.00.
STSA has an Overall Score of 47. Find out what this means to you and get the rest of the rankings on STSA!